However, in a subgroup of individuals with anti-insulin autoantibodies ≥80 nU/mL, 6.2% individuals receiving oral insulin developed T1D, as compared to 10.4% of those receiving placebo (P < .015), suggesting that oral insulin should be tested specifically in this subgroup of individuals [130]. Here, INS is linked to type 1 diabetes mellitus.